Peter Bou Dib: Understanding von Willebrand Factor in Bleeding and Thrombotic Disorders
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared a post on LinkedIn about a recent article by François Depasse et al, published in Expert Review of Hematology:
”Understanding Von Willebrand Factor (VWF): Key to Diagnosing Bleeding and Thrombotic Disorders
Von Willebrand factor is essential for blood clotting and vascular integrity.
Defects in VWF cause the most common inherited bleeding disorder—von Willebrand disease (VWD)—and also play a role in acquired bleeding syndromes and thrombotic conditions.
Key Insights:
- VWD diagnosis relies on a panel of specialized lab tests measuring VWF antigen and activity, factor VIII, and multimer analysis.
- VWF levels vary with age, pregnancy, blood group, inflammation, and other clinical factors.
- Acquired von Willebrand syndrome occurs in settings like cardiovascular disease, hematological malignancies, and autoimmune disorders.
- VWF is involved in thrombotic microangiopathies linked to ADAMTS13 dysfunction.
- Genetic testing complements phenotypic assays, especially for complex cases.”
Title: Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches
Authors: François Depasse, Nikolaus B. Binder, Mariona Bono, Matthias Germer, Michael Heins, Martina Leplatoni, Jürgen Patzke, Stephan Schwers, Michael Spannagl, Peter L. Turecek
Read the Full Article on Expert Review of Hematology
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 1, 2026, 15:24John Chuback: DVT Can Start With Symptoms Many People Brush Off
-
Jun 1, 2026, 15:20Venugopalan Unni: Guidelines for the Evaluation and Management of Acute Pulmonary Embolism in Adults
-
Jun 1, 2026, 15:10Smitirupa Mishra: Standardizing RBC Morphology Reporting – Why ICSH Guidelines Matter?
-
Jun 1, 2026, 14:54Davide Massimi: A Bloodless Approach to Third Space Endoscopy
-
Jun 1, 2026, 14:27Afshan Sumera: Plasma Proteomics Reveals Complement And Coagulation Disruption In Transfusion-Dependent Thalassemia
-
Jun 1, 2026, 13:44Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
-
Jun 1, 2026, 13:39Abdul Mannan: The Moral Injury of Practising Haemato-Oncology in a Resource-Limited Setting
-
Jun 1, 2026, 13:34Filza Aslam: What Does a Patient Journey Partner Actually Do in Bleeding Disorders?
-
Jun 1, 2026, 13:33Darine Ghanem: Advancing Health Equity in Care at the LATAM Meeting